InvestorsHub Logo
Followers 527
Posts 52930
Boards Moderated 0
Alias Born 05/14/2010

Re: Mikesc post# 43085

Monday, 12/07/2015 10:27:24 AM

Monday, December 07, 2015 10:27:24 AM

Post# of 464404
A bit yup! I like this bit and disregarded the end part! Lol.


If 2-73 is shown to slow the rate of cognitive decline more effectively than solanezumab or aducanumab, Anavex investors can expect terrific gains


Use your nose to sniff the winners out!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News